Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: Pathological mutations and polymorphisms

Takayuki Fukuda, Yushiro Yamashita, Shinichiro Nagamitsu, Kenichi Miyamoto, Jing Ji Jin, Iori Ohmori, Yoko Ohtsuka, Katsuko Kuwajima, Shoichi Endo, Tsuyako Iwai, Hidehisa Yamagata, Yasuharu Tabara, Tetsuro Miki, Toyojiro Matsuishi, Ikuko Kondo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A total of 45 different mutations of methyl-CpG-binding protein 2 gene (MECP2) were identified in 145 of 219 Japanese patients with typical or atypical Rett syndrome (RTT) (66.2%). A missense mutation, T158M was the most common mutation of MECP2, identified in 22 (19.1%) patients, followed by four nonsense mutations, R168X (14.8%), R270X (13.0%), R255X (9.6%), and R294X (6.1%) in 115 patients with classical RTT. Two missense mutations, R133C (33.3%) and R306C (23.3%), and a nonsense mutation, R294X (13.3%), were common in 30 patients with atypical RTT, including the preserved speech variant (PSV). Frameshift mutations due to nucleotide deletion or insertion were identified in 22 patients with MECP2 mutations, and one of them had a 3.6 kb deletion encompassing exons 3 and 4. Three patients with classical RTT had a splicing anomaly. The wide spectrum of phenotypic variability in patients with RTT has been considered to be correlated with the mutation type and location in MECP2, and X-inactivation. However, most patients showed a random X-inactivation pattern evaluated by an androgen receptor gene polymorphism in this study, suggesting that a skewed X-inactivation might not be a main modification factor on clinical phenotypes of RTT. In addition, three new missense mutations, P176R, A378V and T479M, were identified in patients with RTT, but also in healthy Japanese, indicating that these mutations are non-pathogenic in Japanese. Information about rare polymorphic variations is very important for the molecular diagnosis of RTT, although rare polymorphic variants might differ among ethnic groups.

Original languageEnglish
Pages (from-to)211-217
Number of pages7
JournalBrain and Development
Volume27
Issue number3 SPEC. ISS.
DOIs
Publication statusPublished - Apr 2005

    Fingerprint

Keywords

  • Methyl-CpG-binding protein 2 gene (MECP2)
  • Rett syndrome (RTT)
  • Single nucleotide polymorphism (SNP)
  • X-inactivation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Fukuda, T., Yamashita, Y., Nagamitsu, S., Miyamoto, K., Jin, J. J., Ohmori, I., Ohtsuka, Y., Kuwajima, K., Endo, S., Iwai, T., Yamagata, H., Tabara, Y., Miki, T., Matsuishi, T., & Kondo, I. (2005). Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: Pathological mutations and polymorphisms. Brain and Development, 27(3 SPEC. ISS.), 211-217. https://doi.org/10.1016/j.braindev.2004.06.003